Consensus EPS · Q4 2026
$2.42
Consensus revenue · Q4 2026
$65.1B
Analysts
11
Expected report
Aug 11, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 11 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $64.1B | $65.1B | $66.5B |
| EPS | $2.39 | $2.42 | $2.45 |
| EBITDA | $1.5B | $1.6B | $1.6B |
| EBIT | $1.4B | $1.4B | $1.5B |
| Net income | $565.6M | $570.3M | $577.4M |
- Revenue$65.1B
- EPS$2.42
- EBITDA$1.6B
- EBIT$1.4B
- Net income$570.3M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q3 2026 | $60.9B | $62.1B | -1.9% | $3.17 | $2.79 | +13.4% |
| Q2 2026 | $65.6B | $65.1B | +0.8% | $2.63 | $2.34 | +12.3% |
- Q3 2026-1.9%+13.4%
- Q2 2026+0.8%+12.3%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Cardinal Health (CAH) Q4 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 1 analyst.
- Low
- $235.00
- Consensus
- $255.13
- Median
- $255.50
- High
- $275.00
- Current
- $220.54
- Upside
- +15.7%
Upside calculated vs most recent trading price of $220.54.
Analyst ratings
Consensus: Buy — based on 33 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 20, 2026 | UBS | maintain | Buy | Buy |
| Jul 9, 2026 | TD Cowen | maintain | Buy | Buy |
| Jul 2, 2026 | B of A Securities | maintain | Buy | Buy |
| May 4, 2026 | JP Morgan | maintain | Neutral | Neutral |
| May 1, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| May 1, 2026 | TD Cowen | maintain | Buy | Buy |
| May 1, 2026 | Citigroup | maintain | Buy | Buy |
| Apr 8, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Feb 24, 2026 | Barclays | maintain | Overweight | Overweight |
| Feb 10, 2026 | Wells Fargo | maintain | Overweight | Overweight |
- Jul 20, 2026UBSBuy
- Jul 9, 2026TD CowenBuy
- Jul 2, 2026B of A SecuritiesBuy
- May 4, 2026JP MorganNeutral
- May 1, 2026Wells FargoOverweight
- May 1, 2026TD CowenBuy
- May 1, 2026CitigroupBuy
- Apr 8, 2026Evercore ISI GroupOutperform
- Feb 24, 2026BarclaysOverweight
- Feb 10, 2026Wells FargoOverweight
Frequently asked questions
Cardinal Health (CAH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks3.57% TTM
- Dividend Profile0.93% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History11 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.